Substituent effect of N-benzylated gramine derivatives that prevent the PP2A inhibition and dissipate the neuronal Ca2+ overload, as a multitarget strategy for the treatment of Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Bioorganic & Medicinal Chemistry

• Publication date

  2018-04-12

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmc.2018.04.019PMID 29656989
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Classics in Chemical Neuroscience: Memantine.

  2017cited by this paper
• Optimization of Bicyclic Lactam Derivatives as NMDA Receptor Antagonists

  2017cited by this paper
• BACE-1 Inhibitors: From Recent Single-Target Molecules to Multitarget Compounds for Alzheimer's Disease.

  2017cited by this paper
• Downregulation of protein phosphatase 2A by apolipoprotein E: Implications for Alzheimer's disease

  2017cited by this paper
• N-Propargylpiperidines with naphthalene-2-carboxamide or naphthalene-2-sulfonamide moieties: Potential multifunctional anti-Alzheimer's agents.

  2017cited by this paper
• Tau and neurodegenerative disease: the story so far

  2016cited by this paper
• Neuroprotective profile of pyridothiazepines with blocking activity of the mitochondrial Na(+)/Ca(2+) exchanger.

  2016cited by this paper
• A systematic evaluation of the safety and toxicity of fingolimod for its potential use in the treatment of acute myeloid leukaemia

  2016cited by this paper
• A Phase IIa Randomized Control Trial of VEL015 (Sodium Selenate) in Mild-Moderate Alzheimer’s Disease

  2016cited by this paper
• Gramine Derivatives Targeting Ca(2+) Channels and Ser/Thr Phosphatases: A New Dual Strategy for the Treatment of Neurodegenerative Diseases.

  2016cited by this paper
• Alzheimer's disease

  2016cited by this paper
• Ligands for Ser/Thr phosphoprotein phosphatases: a patent review (2005-2015)

  2016cited by this paper
• Benzothiazepine CGP37157 and its 2'-isopropyl analogue modulate Ca²⁺ entry through CALHM1.

  2015cited by this paper
• Current Practices in the Treatment of Alzheimer Disease: Where is the Evidence After the Phase III Trials?

  2015cited by this paper
• Cytoplasmic Retention of Protein Phosphatase 2A Inhibitor 2 (I2PP2A) Induces Alzheimer-like Abnormal Hyperphosphorylation of Tau*

  2014cited by this paper
• Okadaic acid-induced Tau phosphorylation in rat brain: role of NMDA receptor.

  2013cited by this paper
• The multifactorial nature of Alzheimer's disease for developing potential therapeutics.

  2013cited by this paper
• Okadaic acid induced neurotoxicity: an emerging tool to study Alzheimer's disease pathology.

  2013cited by this paper
• Calcium channel blockers and dementia

  2013cited by this paper
• Neuroglial alterations in rats submitted to the okadaic acid-induced model of dementia.

  2012cited by this paper
• Benzothiazepine CGP37157 and its isosteric 2'-methyl analogue provide neuroprotection and block cell calcium entry.

  2012cited by this paper
• Mitochondrial dysfunction: a crucial event in okadaic acid (ICV) induced memory impairment and apoptotic cell death in rat brain.

  2011cited by this paper
• Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer's disease.

  2011cited by this paper
• Induction of oxidative DNA damage by the marine toxin okadaic acid depends on human cell type.

  2011cited by this paper
• Okadaic acid (ICV) induced memory impairment in rats: a suitable experimental model to test anti-dementia activity.

  2010cited by this paper
• Calcium hypothesis of Alzheimer’s disease

  2010cited by this paper
• Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders

  2010cited by this paper
• Mechanism of okadaic acid‐induced neuronal death and the effect of estrogens

  2009cited by this paper
• Structure of protein phosphatase 2A core enzyme bound to tumor-inducing toxins.

  2006cited by this paper
• Altered levels of PP2A regulatory B/PR55 isoforms indicate role in neuronal differentiation

  2006cited by this paper
• Involvement of I2PP2A in the abnormal hyperphosphorylation of tau and its reversal by Memantine.

  2006cited by this paper
• Effects of microcystins over short- and long-term memory and oxidative stress generation in hippocampus of rats.

  2006cited by this paper
• Involvement of in the abnormal hyperphosphorylation of tau and its reversal by Memantine

  2006cited by this paper
• Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation

  2005cited by this paper
• Downregulation of Protein Phosphatase 2A Carboxyl Methylation and Methyltransferase May Contribute to Alzheimer Disease Pathogenesis

  2004cited by this paper
• Injection of okadaic acid into the meynert nucleus basalis of rat brain induces decreased acetylcholine level and spatial memory deficit.

  2004cited by this paper
• Fluorine in Medicinal Chemistry

  2004cited by this paper
• Okadaic acid mediates tau phosphorylation via sustained activation of the L-voltage-sensitive calcium channel.

  2003cited by this paper
• Importance of the C28-C38 hydrophobic domain of okadaic acid for potent inhibition of protein serine-threonine phosphatases 1 and 2A.

  2001cited by this paper
• An NMDA Receptor Signaling Complex with Protein Phosphatase 2A

  2001cited by this paper
• Novel marine-derived halogen-containing gramine analogues induce vasorelaxation in isolated rat aorta.

  2001cited by this paper
• Possible NMDA antagonist properties of drugs that affect high pressure neurological syndrome

  1994cited by this paper
• Alzheimer's Disease: A Central Role for Amyloid

  1994cited by this paper
• Calcium Channel Currents in Undifferentiated Human Neuroblastoma (SH‐SY5Y) Cells: Actions and Possible Interactions of Dihydropyridines and ω‐Conotoxin

  1994cited by this paper
• Inhibitory effect of okadaic acid derivatives on protein phosphatases. A study on structure-affinity relationship.

  1992cited by this paper
• Alzheimer's disease: the amyloid cascade hypothesis.

  1992cited by this paper
• Ionic changes induced by excitatory amino acids in the rat cerebral cortex.

  1987cited by this paper
• Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability.

  1986cited by this paper
• Selective loss of central cholinergic neurons in Alzheimer's disease.

  1976cited by this paper

• An Insight into the Recent Advancement in Anti-Alzheimer's Potential of Indole Derivatives and their SAR Study.

  2025cites this paper
• Evaluation of the neuroprotective efficacy of the gramine derivative ITH12657 against NMDA-induced excitotoxicity in the rat retina

  2024cites this paper
• Recent Developments of Gramine: Chemistry and Biological Activity

  2023cites this paper
• Beneficial effects of physical exercise and an orally active mGluR2/3 antagonist pro-drug on neurogenesis and behavior in an Alzheimer's amyloidosis model

  2023cites this paper
• (±)-BIGI-3h: Pentatarget-Directed Ligand combining Cholinesterase, Monoamine Oxidase, and Glycogen Synthase Kinase 3β Inhibition with Calcium Channel Antagonism and Antiaggregating Properties for Alzheimer's Disease.

  2021cites this paper
• Multitarget Therapeutic Strategies for Alzheimer's Disease: Review on Emerging Target Combinations

  2020cites this paper
• Identification of tetracyclic lactams as NMDA receptor antagonists with potential application in neurological disorders.

  2020cites this paper
• Chrysophanol improves memory ability of d-galactose and Aβ25–35 treated rat correlating with inhibiting tau hyperphosphorylation and the CaM–CaMKIV signal pathway in hippocampus

  2020cites this paper
• Design and synthesis of multipotent 3-aminomethylindoles and 7-azaindoles with enhanced protein phosphatase 2A-activating profile and neuroprotection.

  2018cites this paper